What does lash group do?
Empowering patient engagement To improve medication adherence, we engage patients where they are in their healthcare journey and in life. Through personalized interventions and treatments that drive behavioral change, we help improve not just outcomes, but a patient's care experience.
What is Allergan patient assistance program?
The Allergan Patient Assistance Program (PAP) provides Allergan medicines at no cost to eligible patients. If the patient qualifies, up to a twelve-month eligibility for the requested medication(s) or device(s) is approved for shipment to the patient's licensed prescriber for dispensing.
Does Roche have a patient assistance program?
For patients who cannot afford certain drugs. Call for information.
How do you qualify for free eliquis?
You may be eligible for the Free 30-Day Trial Offer for ELIQUIS® (apixaban) if:You have not previously filled a prescription for ELIQUIS;You have a valid 30-day prescription for ELIQUIS;You are being treated with ELIQUIS for an FDA-approved indication that an HCP has planned for more than 35 days of treatment;More items...
What is AbbVie Assistance Program?
Patient Assistance Application Overview myAbbVie Assist provides free medicine to qualifying patients. If you are uninsured or have limited insurance coverage, you may be eligible to receive prescribed AbbVie medication at no cost from our Program.
Does AbbVie have a patient assistance program?
We believe that people who need our medicines should be able to get them. That's why myAbbVie Assist provides free AbbVie medicine to qualifying patients. If you have any questions, visit the FAQs or call us at 1-800-222-6885. AbbVie is committed to helping patients get the medicines they need.
What drugs does Roche make?
Drugs produced by Roche include: Accutane/RoAccutane (isotretinoin), for severe (nodular) acne vulgaris - no longer sold under Accutane brand name but is still available as RoAccutane, other brand names and Isotretinoin generics. Actemra/RoActemra (tocilizumab), for rheumatoid arthritis.
Who makes mycophenolic?
by Apotex. Founded in 1974, Apotex Inc. is Canada's largest pharmaceutical maker and distributes about 300 drugs in the U.S. Apotex serves 100 countries through its range of product offerings.
Welcome, Innovator!
Visit with AB team members during the event at our booth, keynote, and series of sessions.
Join us for a State of the Industry discussion
State of the Industry - Navigating Patient Access Challenges Amid an Ever-Evolving Policy and Payer Landscape Date: Tues. 6/28 Time: 8:45am – 9:30am ET Speaker: Corey Ford, MHA, Sr.
Listen in on an exciting keynote on the acceleration of technology
Acceleration of technology development and innovation - the "new normal” Date: Tues. 6/28 Time: 10:45am – 11:30am ET
Learn ways to advance your patient support programs
Session: You’ve Created a Good Patient Support Program, Now Make it Great. Date: Wed. 6/29 Time: 3:15 - 4:00pm ET
How the program works
Our prescription products are available to patients who meet our eligibility requirements. Currently, Gleostine ® is the principal product being administered through the patient assistance program.
Am I eligible?
It’s easy to find out if you qualify for NextSource Cares ™ Patient Assistance Program. Just answer these simple questions:
How do I apply?
If you answered ‘yes’ to all the questions above, we invite you to download our NextSource Cares ™ application.
Driving speed to therapy
We pair advanced technologies with expert human support to drive faster access to therapy and enhance the patient experience. By leveraging industry-leading innovations, such as an AI-powered digital assistant that makes payer calls, we increase automation, accuracy, and efficiency every step of the way.
Reducing Financial Burdens
Cost should never be a barrier to care. That's why we work closely with manufacturers to develop unique copay assistance programs that accelerate patients access to therapy. Our copay services comply with industry rules and standards, yet are flexible to meet the needs of broad patient populations.
Empowering patient engagement
To improve medication adherence, we engage patients where they are in their healthcare journey and in life. Through personalized interventions and treatments that drive behavioral change, we help improve not just outcomes, but a patient's care experience.
